Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

By USA Today | Oct 21, 2024 at 01:30 PM EST

Eli Lilly is selling Zepbound in vials at a reduced cost. They have filed lawsuits against medical spas and online vendors selling products falsely claiming to contain tirzepatide, a key ingredient in Zepbound. The lawsuits aim to protect consumers from false claims and risks.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.